In Hee Kim

13PUBLICATIONS
87CO-AUTHORS
Epidemiological modellingPharmaceutical delivery technologiesMedical biochemistry - proteins and peptides (incl. medical proteomics)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 11, 2025
Phase I Study to Evaluate the Effect of Hepatic Impairment on Pharmacokinetics and Safety of Tegoprazan, a Potassium Competitive Acid Blocker.

Anhye Kim, Dongseong Shin, Youlim Seo

|Mar 22, 2022
A Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients.

Hyung Joon Kim, Ju Hyun Kim, Jong Eun Yeon

|Feb 12, 2021
Maximal diameter of liver abscess independently predicts prolonged hospitalization and poor prognosis in patients with pyogenic liver abscess.

Chang Hun Lee, Hoon Gil Jo, Eun Young Cho

|May 27, 2020
Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase.

Han Ah Lee, Hyun Woong Lee, In Hee Kim

|May 09, 2020
Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovir.

Tae Seop Lim, Hyun Woong Lee, Jung Il Lee

|Feb 01, 2020
Real-Life Effectiveness and Safety of Sofosbuvir-Based Therapy in Genotype 2 Chronic Hepatitis C Patients in South Korea, with Emphasis on the Ribavirin Dose.

Eun Sun Jang, Kyung-Ah Kim, Young Seok Kim

Pageof 3

Frequent Collaborators

5 joint publications

Young Seok Kim

4 joint publications

Chang Hun Lee

4 joint publications

Sook-Hyang Jeong

4 joint publications

Byung-Seok Lee